Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Net Shares Issued and Repurchased (2012 - 2016)

Curis' (CRIS) quarterly Net Shares Issued and Repurchased came in at $2.3 million in Q1 2016, up 92.43% on a YoY basis from $1.2 million in Q2 2015, and down 29.74% quarter-over-quarter from $3.2 million in Q4 2015.

Analysis

Curis (CRIS) Net Shares Issued and Repurchased (2012 - 2016) Analysis & Trends

Curis (CRIS) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $2.3 million the latest figure, recorded in Q1 2016.

  • For the quarter ending Q1 2016, Net Shares Issued and Repurchased rose 92.43% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2016 stood at $2.3 million (up 92.43% YoY), and the FY2015 full-year result was $3.2 million, up 41.87% from the prior year.
  • Net Shares Issued and Repurchased eased to $2.3 million in Q1 2016 per CRIS's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $3.2 million in Q4 2015 and bottomed at $1.2 million in Q1 2015.
  • Historically, Net Shares Issued and Repurchased has averaged $2.0 million across 5 years, with a median of $2.0 million in 2012.
  • The sharpest annual moves came in 2014 and 2016: Net Shares Issued and Repurchased retreated 20.46% in 2014, then surged 92.43% in 2016.
  • Over 5 years, Net Shares Issued and Repurchased stood at $1.7 million in 2012, then jumped by 73.18% to $2.9 million in 2013, then retreated by 20.46% to $2.3 million in 2014, then surged by 41.87% to $3.2 million in 2015, then dropped by 29.74% to $2.3 million in 2016.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.3 million, $3.2 million, and $1.2 million for Q1 2016, Q4 2015, and Q1 2015 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Curis 2.57 Mn -3.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 2.27 Mn
Dec 31, 2015 3.23 Mn
Mar 31, 2015 1.18 Mn
Dec 31, 2014 2.28 Mn
Mar 31, 2014 1.36 Mn
Dec 31, 2013 2.86 Mn
Mar 31, 2013 1.25 Mn
Dec 31, 2012 1.65 Mn